Journal
Cancer Cell
Publication Date
9-11-2023
Volume
41
Issue
9
First Page
1567
Last Page
1585.e7
Document Type
Open Access Publication
DOI
10.1016/j.ccell.2023.07.013
Rights and Permissions
Liang WW, Lu RJ, Jayasinghe RG, Foltz SM, Porta-Pardo E, Geffen Y, Wendl MC, Lazcano R, Kolodziejczak I, Song Y, Govindan A, Demicco EG, Li X, Li Y, Sethuraman S, Payne SH, Fenyö D, Rodriguez H, Wiznerowicz M, Shen H, Mani DR, Rodland KD, Lazar AJ, Robles AI, Ding L; Clinical Proteomic Tumor Analysis Consortium. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin. Cancer Cell. 2023 Sep 11;41(9):1567-1585.e7. doi: 10.1016/j.ccell.2023.07.013. Copyright 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Liang, Wen-Wei; Lu, Rita Jui-Hsien; Jayasinghe, Reyka G; Foltz, Steven M; Wendl, Michael C; Song, Yizhe; Govindan, Akshay; Li, Xiang; Li, Yize; Sethuraman, Sunantha; Ding, Li; and et al., "Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin." Cancer Cell. 41, 9. 1567 - 1585.e7. (2023).
https://digitalcommons.wustl.edu/oa_4/3098
Additional Links
Supplemental material is available for this article at publisher site.
